Literature DB >> 7745750

Human immunodeficiency virus type 1 preintegration complexes containing discontinuous plus strands are competent to integrate in vitro.

M D Miller1, B Wang, F D Bushman.   

Abstract

Despite intensive study, the mechanism by which many retroviruses complete reverse transcription has remained unclear. Most retroviruses and all lentiviruses fail to synthesize a full-length second strand of the viral cDNA (plus strand) efficiently in infected cells. For human immunodeficiency virus type 1, we find in synchronous infection experiments that full-length plus strands are rare (< 1% of products) at times when integration is likely taking place. Subviral nucleoprotein complexes containing such discontinuous cDNA can be extracted from infected cells and used to generate integration products in vitro. Analysis of such integration products using two-dimensional gel electrophoresis revealed that the discontinuous viral DNA was efficiently integrated into an added target DNA. These data support a model in which the discontinuities in the plus strand need not be sealed until after integration, potentially by the enzymes that are already thought to repair DNA gaps at the junctions between host and viral DNA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745750      PMCID: PMC189122          DOI: 10.1128/JVI.69.6.3938-3944.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  The role of Moloney murine leukemia virus RNase H activity in the formation of plus-strand primers.

Authors:  A J Rattray; J J Champoux
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

2.  Correct integration of retroviral DNA in vitro.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

3.  Synthesis in cell culture of the gapped linear duplex DNA of the slow virus visna.

Authors:  H E Blum; J D Harris; P Ventura; D Walker; K Staskus; E Retzel; A T Haase
Journal:  Virology       Date:  1985-04-30       Impact factor: 3.616

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Visna virus DNA: discovery of a novel gapped structure.

Authors:  J D Harris; J V Scott; B Traynor; M Brahic; L Stowring; P Ventura; A T Haase; R Peluso
Journal:  Virology       Date:  1981-09       Impact factor: 3.616

6.  Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. I. Kinetics of synthesis and size of minus- and plus-strand transcripts.

Authors:  L R Boone; A M Skalka
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

7.  Synthesis of plus strands of retroviral DNA in cells infected with avian sarcoma virus and mouse mammary tumor virus.

Authors:  H J Kung; Y K Fung; J E Majors; J M Bishop; H E Varmus
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

8.  Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. II. Evidence for a strand displacement mechanism in plus-strand synthesis.

Authors:  L R Boone; A M Skalka
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

9.  A detailed model of reverse transcription and tests of crucial aspects.

Authors:  E Gilboa; S W Mitra; S Goff; D Baltimore
Journal:  Cell       Date:  1979-09       Impact factor: 41.582

10.  Kinetic analysis of HIV-1 early replicative steps in a coculture system.

Authors:  P Barbosa; P Charneau; N Dumey; F Clavel
Journal:  AIDS Res Hum Retroviruses       Date:  1994-01       Impact factor: 2.205

View more
  42 in total

1.  Repair of gaps in retroviral DNA integration intermediates.

Authors:  K E Yoder; F D Bushman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Retroviral cDNA integration: stimulation by HMG I family proteins.

Authors:  L Li; K Yoder; M S Hansen; J Olvera; M D Miller; F D Bushman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.

Authors:  L Li; J M Olvera; K E Yoder; R S Mitchell; S L Butler; M Lieber; S L Martin; F D Bushman
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

4.  Integrase-lexA fusion proteins incorporated into human immunodeficiency virus type 1 that contains a catalytically inactive integrase gene are functional to mediate integration.

Authors:  M L Holmes-Son; S A Chow
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Nonintegrating foamy virus vectors.

Authors:  David R Deyle; Yi Li; Erik M Olson; David W Russell
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

6.  Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.

Authors:  Boris Kantor; Matthew Bayer; Hong Ma; Jude Samulski; Chengwen Li; Thomas McCown; Tal Kafri
Journal:  Mol Ther       Date:  2010-12-14       Impact factor: 11.454

Review 7.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

8.  Retrotransposon suicide: formation of Ty1 circles and autointegration via a central DNA flap.

Authors:  David J Garfinkel; Karen M Stefanisko; Katherine M Nyswaner; Sharon P Moore; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

Review 9.  Integration-deficient lentiviral vectors: a slow coming of age.

Authors:  Klaus Wanisch; Rafael J Yáñez-Muñoz
Journal:  Mol Ther       Date:  2009-06-02       Impact factor: 11.454

10.  ts1-Induced spongiform encephalomyelopathy: physical forms of high-mobility DNA in spinal cord tissues of paralyzed mice are products of premature termination of reverse transcription.

Authors:  P F Szurek; B R Brooks
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.